ABT-418
id:
abt-418-237-15971048
title:
ABT-418
text:
ABT-418 is a drug developed by Abbott, that has nootropic, neuroprotective and anxiolytic effects, and has been researched for treatment of both Alzheimer's disease and ADHD. It acts as an agonist at neural nicotinic acetylcholine receptors, subtype-selective binding with high affinity to the α4β2, α7/5-HT3, and α2β2 nicotinic acetylcholine receptors but not α3β4 receptors ABT-418 was reasonably effective for both applications and fairly well tolerated, but produced some side effects, principall
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/ABT-418
date created:
date modified:
2024-02-09T06:13:19Z
main entity:
{"identifier":"Q4650418","url":"https://www.wikidata.org/entity/Q4650418"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/8f/ABT-418.svg","width":512,"height":314}
fields total:
13
integrity:
15